Mirae Asset Global ETFs Holdings’s Niagen Bioscience NAGE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85K	Buy	26,648 +1,496	+6%	+$6.07K	﹤0.01%	2899
2026 Q1	$111K	Buy	25,152 +612	+2%	+$3.3K	﹤0.01%	2622
2025 Q4	$156K	Buy	24,540 +599	+3%	+$4.17K	﹤0.01%	2463
2025 Q3	$223K	Sell	23,941 -4,597	-16%	-$46.4K	﹤0.01%	2269
2025 Q2	$411K	Sell	28,538 -789	-3%	-$7.79K	﹤0.01%	1911
2025 Q1	$202K	Buy	29,327 +1,248	+4%	+$7.84K	﹤0.01%	2314
2024 Q4	$149K	Buy	28,079 +1,216	+5%	+$6.66K	﹤0.01%	2540
2024 Q3	$98K	Buy	+26,863	New	+$84.5K	﹤0.01%	2722

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mirae Asset Global ETFs Holdings's NAGE Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Niagen Bioscience (NAGE) stake by 5.9% in Q2 2026, buying an estimated $6.07K and bringing the position to 26,648 shares worth $85K. The position accounts for ﹤0.01% of the portfolio, ranked #2899.

Mirae Asset Global ETFs Holdings first reported a position in NAGE in Q3 2024 and has held it in 8 quarters since. The position peaked at $411K in Q2 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

Mirae Asset Global ETFs Holdings held 26,648 shares of Niagen Bioscience worth $85K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 1,496 Niagen Bioscience shares in Q2 2026, an estimated $6.07K.
Niagen Bioscience made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2899 holding.
Mirae Asset Global ETFs Holdings first reported a position in Niagen Bioscience in Q3 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Niagen Bioscience position peaked at $411K in Q2 2025.
140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.